Publications

  1. Myasoedova E. Predicting treatment response to methotrexate: are we closer to solving the enigma? Rheumatology (Oxford) 2024 May 3; 63 (6):1479-1480
    View PubMed
  2. Stevens MA, Dykhoff HJ, Kronzer VL, Myasoedova E, Davis JM 3rd, Duarte-Garcia A, Crowson CS. Disparities in multimorbidity and comorbidities in rheumatoid arthritis by sex across the lifespan. Rheumatology (Oxford). 2024 May 3; 63 (6):1639-1648
    View PubMed
  3. Myasoedova E, Matteson EL. Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis. Curr Opin Rheumatol. 2024 May 1; 36 (3):203-208 Epub 2024 Feb 23
    View PubMed
  4. Crowson CS, Atkinson EJ, Kronzer VL, Kimbrough BA, Arment CA, Peterson LS, Wright K, Mason TG 2nd, Bekele DI, Davis JM 3rd, Myasoedova E. Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis. Ann Rheum Dis. 2024 Apr 11; 83 (5):556-563
    View PubMed
  5. Kimbrough BA, Crowson CS, Davis JM 3rd, Matteson EL, Myasoedova E. Decline in Incidence of Extra-Articular Manifestations of Rheumatoid Arthritis: A Population-Based Cohort Study. Arthritis Care Res (Hoboken). 2024 Apr; 76 (4):454-462 Epub 2023 Dec 10
    View PubMed
  6. Kimbrough BA, Crowson CS, Lennon RJ, Davis JM 3rd, Strangfeld A, Myasoedova E. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2024 Apr; 65:152386 Epub 2024 Jan 15
    View PubMed
  7. Kronzer VL, Davis JM, Hanson AC, Sparks JA, Myasoedova E, Duarte-Garcia A, Hinze AM, Makol A, Koster MJ, Vassallo R, Warrington KJ, Wright K, Crowson CS. Association between sinusitis and incident rheumatic diseases: a population-based study. RMD Open. 2024 Feb 22; 10 (1)
    View PubMed
  8. Montes D, Hulshizer CA, Myasoedova E, Davis JM 3rd, Hanson AC, Duarte-Garcia A, Figueroa-Parra G, Chevet B, Crowson CS. Utilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort. RMD Open. 2023 Nov; 9 (4)
    View PubMed
  9. Larsen RA, Constantopoulos E, Kodishala C, Lovering E, Kumar R, Hulshizer CA, Lennon RJ, Crowson CS, Nguyen AT, Myasoedova E. Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritis. Rheumatology (Oxford). 2023 Oct 23; 62 (SI3):SI296-SI303
    View PubMed
  10. Churchill R, Sykora D, Castrichini M, Arment C, Myasoedova E, Elwazir M, Bois J, Young K, Rosenbaum A. Clinical Response to Tumor Necrosis Factor-alpha Inhibitor Therapy in the Management of Cardiac Sarcoidosis. Am J Cardiol. 2023 Oct 15; 205:20-27 Epub 2023 Aug 12
    View PubMed
  11. Mousa J, Peterson MN, Crowson CS, Achenbach SJ, Atkinson EJ, Amin S, Khosla S, Davis JM 3rd, Myasoedova E. Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid Arthritis. J Rheumatol. 2023 Oct; 50 (10):1279-1286 Epub 2023 July 01
    View PubMed
  12. Crowson LP, Davis JM 3rd, Hanson AC, Myasoedova E, Kronzer VL, Makol A, Peterson LS, Bekele DI, Crowson CS. Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018. Semin Arthritis Rheum. 2023 Aug; 61:152219 Epub 2023 May 05
    View PubMed
  13. Myasoedova E, Kurmann RD, Achenbach SJ, Wright K, Arment CA, Dunlay SM, Davis JM 3rd, Crowson CS. Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions. J Rheumatol. 2023 Jul; 50 (7):881-888 Epub 2023 Mar 15
    View PubMed
  14. Cunningham KY, Hur B, Gupta VK, Arment CA, Wright KA, Mason TG, Peterson LS, Bekele DI, Schaffer DE, Bailey ML, Delger KE, Crowson CS, Myasoedova E, Zeng H, Rodriguez M, Weyand CM, Davis JM 3rd, Sung J. Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity. Sci Rep. 2023 Apr 1; 13 (1):5360 Epub 2023 Apr 01
    View PubMed
  15. Crowson CS, Gunderson TM, Davis JM 3rd, Myasoedova E, Kronzer VL, Coffey CM, Atkinson EJ. Using Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-Based Cohort of Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 Feb; 75 (2):210-219 Epub 2022 Sept 15
    View PubMed
  16. Kodishala C, Hulshizer CA, Kronzer VL, Davis JM 3rd, Ramanan VK, Vassilaki M, Mielke MM, Crowson CS, Myasoedova E. Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study. J Rheumatol. 2023 Jan; 50 (1):48-55 Epub 2022 July 15
    View PubMed
  17. Mousa J, Peterson MN, Crowson CS, Achenbach SJ, Atkinson EJ, Amin S, Khosla S, Davis JM III, Myasoedova E. Validating the fracture risk assessment tool score in a US population-based study of patients with rheumatoid arthritis. Journal of Rheumatology. 2023; 50 (10):1279-86
  18. Kronzer VL, Dykhoff HJ, Stevens MA, Myasoedova E, Davis JM 3rd, Crowson CS. Racial Differences in Multimorbidity and Comorbidities in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2023 Jan; 75 (1):76-84 Epub 2022 Oct 31
    View PubMed
  19. Myasoedova E, Kurmann RD, Achenbach SJ, Wright K, Arment CA, Dunlay SM, Davis JM III, Crowson CS. Trends in incidence of chronic heart failure in patients with rheumatoid arthritis: a population-based study validating different heart failure definitions. Journal of Rheumatology. 2023; 50 (7):881-8
  20. Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM 3rd, Myasoedova E, Crowson CS. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort. Arthritis Care Res (Hoboken). 2022 Dec; 74 (12):2042-2049 Epub 2022 Aug 10
    View PubMed
  21. Kronzer VL, Lennon RJ, Sparks JA, Myasoedova E, Davis JM, Crowson CS. Association between work physical activity, dietary factors, and risk of rheumatoid arthritis. Semin Arthritis Rheum. 2022 Dec; 57:152100 Epub 2022 Sept 19
    View PubMed
  22. Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Crowson CS, van Riel P, Kitas GD, Graham I, Dahlqvist SR, Karpouzas G, Myasoedova E, Gonzalez-Gay MA, Sfikakis PP, Tektonidou MG, Lazarini A, Vassilopoulos D, Kuriya B, Hitchon CA, Stoenoiu MS, Durez P, Pascual-Ramos V, Galarza-Delgado DA, Faggiano P, Misra DP, Borg A, Mu R, Mirrakhimov EM, Gheta D, Myasoedova S, Krougly L, Popkova T, Tuchynova A, Tomcik M, Vrablik M, Lastuvka J, Horak P, Medkova H, Semb AG. An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countries. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3; 8 (6):539-548
    View PubMed
  23. Duong SQ, Crowson CS, Athreya A, Atkinson EJ, Davis JM 3rd, Warrington KJ, Matteson EL, Weinshilboum R, Wang L, Myasoedova E. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data. Arthritis Res Ther. 2022 Jul 1; 24 (1):162 Epub 2022 July 01
    View PubMed
  24. Myasoedova E, Athreya AP, Crowson CS, Davis JM 3rd, Warrington KJ, Walchak RC, Carlson E, Kalari KR, Bongartz T, Tak PP, van Vollenhoven RF, Padyukov L, Emery P, Morgan A, Wang L, Weinshilboum RM, Matteson EL, Pharmacogenetics of Methotrexate in Rheumatoid Arthritis Consortium. Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach. Arthritis Care Res (Hoboken). 2022 Jun; 74 (6):879-888 Epub 2022 Apr 06
    View PubMed
  25. Challener GJ, Myasoedova E, Crowson CS, Giblon RE, Atkinson EJ, Davis JM 3rd. Body mass index trend and variability in rheumatoid arthritis. Clin Rheumatol. 2022 Feb; 41 (2):349-355 Epub 2021 Sept 11
    View PubMed
  26. Myasoedova E, Davis JM 3rd, Kronzer VL, Giblon RE, Atkinson EJ, LeBrasseur NK, Crowson CS. The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study. Semin Arthritis Rheum. 2022 Feb; 52:151941 Epub 2021 Dec 31
    View PubMed
  27. de Thurah A, Marques A, de Souza S, Crowson CS, Myasoedova E. Future challenges in rheumatology - is telemedicine the solution? Ther Adv Musculoskelet Dis. 2022; 14:1759720X221081638 Epub 2022 Mar 17
    View PubMed
  28. De Cock D, Myasoedova E, Aletaha D, Studenic P. Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs). Ther Adv Musculoskelet Dis. 2022; 14:1759720X221105978 Epub 2022 June 30
    View PubMed
  29. Vassilaki M, Crowson CS, Davis Iii JM, Duong SQ, Jones DT, Nguyen A, Mielke MM, Vemuri P, Myasoedova E. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging. J Alzheimers Dis. 2022; 89 (3):943-954
    View PubMed
  30. Crowson CS, Gunderson TM, Dykhoff HJ, Myasoedova E, Atkinson EJ, Kronzer VL, Coffey CM, Davis Iii JM. Comprehensive assessment of multimorbidity burden in a population-based cohort of patients with rheumatoid arthritis. RMD Open. 2022 Jan; 8 (1)
    View PubMed
  31. O'Neill KD, Marks KE, Sinicrope PS, Crowson CS, Symons D, Myasoedova E, Davis JM 3rd. Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis-A Cross-Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve When Goals Are Discussed. ACR Open Rheumatol. 2021 Dec; 3 (12):870-878 Epub 2021 Sept 18
    View PubMed
  32. Wilton KM, Achenbach SJ, Davis JM 3rd, Myasoedova E, Matteson EL, Crowson CS. Erectile Dysfunction and Cardiovascular Risk in Men With Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol. 2021 Nov; 48 (11):1641-1647 Epub 2021 Jan 15
    View PubMed
  33. Gunderson TM, Myasoedova E, Davis JM 3rd, Crowson CS. Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study. J Rheumatol. 2021 Nov; 48 (11):1648-1654 Epub 2021 Feb 15
    View PubMed
  34. Sorour AA, Kurmann RD, Shahin YE, Crowson CS, Achenbach SJ, Mankad R, Myasoedova E. Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis. J Rheumatol. 2021 Oct; 48 (10):1508-1511 Epub 2021 Jan 15
    View PubMed
  35. Peterson MN, Dykhoff HJ, Crowson CS, Davis JM 3rd, Sangaralingham LR, Myasoedova E. Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study. Arthritis Res Ther. 2021 Sep 18; 23 (1):244 Epub 2021 Sept 18
    View PubMed
  36. Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM 3rd, Sung J. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med. 2021 Sep 14; 13 (1):149 Epub 2021 Sept 14
    View PubMed
  37. Myasoedova E, Davis JM, Roger VL, Achenbach SJ, Crowson CS. Improved Incidence of Cardiovascular Disease in Patients With Incident Rheumatoid Arthritis in the 2000s: A Population-based Cohort Study. J Rheumatol. 2021 Sep; 48 (9):1379-1387 Epub 2021 Feb 15
    View PubMed
  38. Kronzer VL, Crowson CS, Davis JM 3rd, Vassilaki M, Mielke MM, Myasoedova E. Trends in incidence of dementia among patients with rheumatoid arthritis: A population-based cohort study. Semin Arthritis Rheum. 2021 Aug; 51 (4):853-857 Epub 2021 June 15
    View PubMed
  39. Semb AG, Rollefstad S, Ikdahl E, Wibetoe G, Sexton J, Crowson C, van Riel P, Kitas G, Graham I, Rantapaa-Dahlqvist S, Karpouzas GA, Myasoedova E, Gonzalez-Gay MA, Sfikakis PP, Tektonidou MG, Lazarini A, Vassilopoulos D, Kuriya B, Hitchon C, Stoenoiu MS, Durez P, Pascual-Ramos V, Galarza-Delgado DA, Faggiano P, Misra DP, Borg AA, Mu R, Mirrakhimov EM, Gheta D, Douglas K, Agarwal V, Myasoedova S, Krougly L, Valentinovna Popkova T, Tuchynova A, Tomcik M, Vrablik M, Lastuvka J, Horak P, Medkova HK, Kerola AM, SURF-RA collaborators. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit. RMD Open. 2021 Jul; 7 (2)
    View PubMed
  40. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis J 3rd. Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 Feb; 73 (2):180-187
    View PubMed
  41. Myasoedova E, Karmacharya P, Duarte-Garcia A, Davis JM 3rd, Murad MH, Crowson CS. Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2020 Dec; 50 (6):1348-1356 Epub 2020 Apr 09
    View PubMed
  42. Davis JM 3rd, Myasoedova E, Gunderson TM, Crowson CS. Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort. Rheumatol Ther. 2020 Dec; 7 (4):979-991 Epub 2020 Oct 28
    View PubMed
  43. Duarte-Garcia A, Myasoedova E, Karmacharya P, Hocaoglu M, Murad MH, Warrington KJ, Crowson CS. Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis. Autoimmun Rev. 2020 Dec; 19 (12):102688 Epub 2020 Oct 22
    View PubMed
  44. Kronzer VL, Tarabochia AD, Lobo Romero AS, Tan NY, O'Byrne TJ, Crowson CS, Turley TN, Myasoedova E, Davis JM 3rd, Raphael CE, Gulati R, Hayes SN, Tweet MS. Lack of Association of Spontaneous Coronary Artery Dissection With Autoimmune Disease. J Am Coll Cardiol. 2020 Nov 10; 76(19):2226-2234.
    View PubMed
  45. Karmacharya P, Duarte-Garcia A, Dubreuil M, Murad MH, Shahukhal R, Shrestha P, Myasoedova E, Crowson CS, Wright K, Davis JM 3rd. Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2020 May; 72 (5):733-749 Epub 2020 Apr 01
    View PubMed
  46. Myasoedova E, Davis J, Matteson EL, Crowson CS. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014. Ann Rheum Dis. 2020 Apr; 79 (4):440-444 Epub 2020 Feb 17
    View PubMed
  47. Myasoedova E, De Thurah A, Erpelding ML, Schneeberger EE, Maribo T, Citera G, Davis JM, Matteson EL, Crowson CS, Fautrel B, Guillemin F. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire. Semin Arthritis Rheum. 2020 Apr; 50 (2):261-265 Epub 2019 Sept 11
    View PubMed
  48. Myasoedova E, Davis JM 3rd, Matteson EL, Achenbach SJ, Setoguchi S, Dunlay SM, Roger VL, Gabriel SE, Crowson CS. Increased hospitalization rates following heart failure diagnosis in rheumatoid arthritis as compared to the general population. Semin Arthritis Rheum. 2020 Feb; 50 (1):25-29 Epub 2019 July 15
    View PubMed
  49. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis JM 3rd. Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis. Mayo Clin Proc. 2019 Dec; 94 (12):2488-2498 Epub 2019 Nov 20
    View PubMed
  50. Myasoedova E, Crowson CS, Giblon RE, McCarthy-Fruin K, Schaffer DE, Wright K, Matteson EL, Davis JM 3rd. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial. Clin Rheumatol. 2019 Nov; 38 (11):3025-3032 Epub 2019 July 01
    View PubMed
  51. Coffey CM, Crowson CS, Myasoedova E, Matteson EL, Davis JM 3rd. Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity. Mayo Clin Proc. 2019 Nov; 94 (11):2241-2248 Epub 2019 Oct 13
    View PubMed
  52. Myasoedova E, Davis JM 3rd, Achenbach SJ, Matteson EL, Crowson CS. Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population. Mayo Clin Proc. 2019 Jun; 94 (6):1035-1039 Epub 2019 May 01
    View PubMed
  53. Raheel S, Matteson EL, Crowson CS, Myasoedova E. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study. Rheumatology (Oxford). 2017 Dec 1; 56 (12):2154-2161
    View PubMed
  54. Myasoedova E, Gabriel SE, Matteson EL, Davis JM 3rd, Therneau TM, Crowson CS. Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA? J Rheumatol. 2017 Jun; 44 (6):732-739 Epub 2017 Apr 01
    View PubMed
  55. Myasoedova E. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk. Curr Opin Rheumatol. 2017 May; 29 (3):277-284
    View PubMed
  56. Zamora-Legoff JA, Myasoedova E, Matteson EL, Achenbach SJ, Crowson CS. Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014. Clin Rheumatol. 2016 Oct; 35 (10):2427-36 Epub 2016 June 22
    View PubMed
  57. Myasoedova E, Chandran A, Ilhan B, Major BT, Michet CJ, Matteson EL, Crowson CS. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease. Ann Rheum Dis. 2016 Mar; 75 (3):560-5 Epub 2015 Jan 30
    View PubMed
  58. Myasoedova E, Crowson CS, Green AB, Matteson EL, Gabriel SE. Longterm blood pressure variability in patients with rheumatoid arthritis and its effect on cardiovascular events and all-cause mortality in RA: a population-based comparative cohort study. J Rheumatol. 2014 Aug; 41 (8):1638-44 Epub 2014 July 01
    View PubMed
  59. Myasoedova E, Gabriel SE, Green AB, Matteson EL, Crowson CS. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study. Arthritis Care Res (Hoboken). 2013 Oct; 65 (10):1592-9
    View PubMed
  60. Akkara Veetil BM, Myasoedova E, Matteson EL, Gabriel SE, Crowson CS. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study. J Rheumatol. 2013 Jul; 40 (7):1082-8 Epub 2013 May 01
    View PubMed
  61. Myasoedova E, Davis JM 3rd, Crowson CS, Roger VL, Karon BL, Borgeson DD, Therneau TM, Matteson EL, Rodeheffer RJ, Gabriel SE. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum. 2013 Jul; 65 (7):1713-8
    View PubMed
  62. Veetil BM, Myasoedova E, Matteson EL, Gabriel SE, Green AB, Crowson CS. Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study. Arthritis Care Res (Hoboken). 2013 Jun; 65 (6):854-61
    View PubMed
  63. Myasoedova E, Akkara Veetil BM, Matteson EL, Kremers HM, McEvoy MT, Crowson CS. Cardiovascular risk in psoriasis: a population-based analysis with assessment of the framingham risk score. Scientifica (Cairo). 2013; 2013:371569 Epub 2013 Jan 31
    View PubMed
  64. Myasoedova E, Matteson EL, Talley NJ, Crowson CS. Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study. J Rheumatol. 2012 Jul; 39 (7):1355-62 Epub 2012 Apr 01
    View PubMed
  65. Miasoedova EE, Obzherina SV, Sviatova ND, Miasoedova SE. [Predictors of cardiovascular and cerebral complications in patients with rheumatoid arthritis]. Klin Med (Mosk). 2012; 90 (6):46-51
    View PubMed
  66. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE. The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol. 2011 Aug; 38 (8):1601-6 Epub 2011 May 15
    View PubMed
  67. Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. J Rheumatol. 2011 Jun; 38 (6):983-9 Epub 2011 Apr 01
    View PubMed
  68. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken). 2011 May; 63 (5):729-34
    View PubMed
  69. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011 Mar; 70 (3):482-7 Epub 2011 Jan 07
    View PubMed
  70. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63 (3):633-9
    View PubMed
  71. Myasoedova E, Talley NJ, Manek NJ, Crowson CS. Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in olmsted county, Minnesota. Gastroenterol Res Pract. 2011; 2011:745829 Epub 2011 Nov 17
    View PubMed
  72. Crowson CS, Myasoedova E, Davis JM 3rd, Matteson EL, Roger VL, Therneau TM, Fitz-Gibbon P, Rodeheffer RJ, Gabriel SE. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan; 38 (1):29-35 Epub 2010 Oct 15
    View PubMed
  73. Borkhoff CM, Wieland ML, Myasoedova E, Ahmad Z, Welch V, Hawker GA, Li LC, Buchbinder R, Ueffing E, Beaton D, Cardiel MH, Gabriel SE, Guillemin F, Adebajo AO, Bombardier C, Hajjaj-Hassouni N, Tugwell P. Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis. Arthritis Care Res (Hoboken). 2011 Jan; 63(1):39-52.
    View PubMed
  74. Kremers HM, Myasoedova E, Crowson CS, Savova G, Gabriel SE, Matteson EL. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford). 2011 Jan; 50 (1):6-15 Epub 2010 July 13
    View PubMed
  75. Myasoedova E, Davis JM 3rd, Crowson CS, Gabriel SE. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep. 2010 Oct; 12 (5):379-85
    View PubMed
  76. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, Borgeson DD, Therneau TM, Rodeheffer RJ, Gabriel SE. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010 Sep; 69 (9):1665-70 Epub 2010 May 24
    View PubMed
  77. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2010 Jul; 69 (7):1310-4 Epub 2009 Oct 23
    View PubMed
  78. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010 Jun; 62 (6):1576-82
    View PubMed
  79. Myasoedova E, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: a step forward. Curr Opin Rheumatol. 2010 May; 22(3):342-7.
    View PubMed
  80. Miasoedova EE, Miasoedova SE, Obzherina SV. [Asymptomatic carotid atherosclerosis and its predictors in patients with rheumatoid arthritis]. Klin Med (Mosk). 2009; 87 (7):37-41
    View PubMed
  81. Miasoedova EE, Nazarov SB. [The response of erythrocytic system of mature rats to acute nitrite intoxication]. Patol Fiziol Eksp Ter. 2004 Apr-Jun; (2):16-8
    View PubMed
  82. Miasoedova EE, Nazarov SB. [Use of alpha-tocopherol in correction of red blood (erythron) system disorders in rats with acute nitrite intoxication]. Eksp Klin Farmakol. 2003 Sep-Oct; 66 (5):35-9
    View PubMed
  83. Miasoedova EE, Nazarov SB. [Comparative characteristic of sodium nitroprusside and sodium nitrite action on erythrophagocytosis in rats in vitro]. Ross Fiziol Zh Im I M Sechenova. 2003 May; 89 (5):613-5
    View PubMed
  84. Miasoedova EE, Golubeva EK, Prorokova MV, Nazarov SB. [Effect of sodium nitroprusside on erythrocyte phagocytosis by peritoneal macrophages in white rats]. Ross Fiziol Zh Im I M Sechenova. 2002 Jan; 88 (1):32-7
    View PubMed